Biomedical subjects
R Barnes
Publications and source records attributed to R Barnes.
The utilization of iron and its complexes by mammalian mitochondria.
Sonicated mitochondria catalyse the reduction of ferric salts, and the subsequent incorporation of Fe(2+) into haem, when provided with a reducing substrate such as succinate or NADH. The rate of haem synthesis was low under aerobic conditions and, after a short lag period, accelerated once anaerobic conditions were achieved; it was insensitive to antimycin A. The lag period was decreased by preincubating the mitochondria with NADH and Fe(3+). Newly formed Fe(2+) was autoxidized rapidly and the consequent O(2) uptake was measured with an oxygen electrode to determine the rate of enzymic formation of Fe(2+) from FeCl(3); this reaction was rapid in sonicated mitochondria provided with NADH or succinate and was insensitive to antimycin A. The reaction was very slow in intact mitochondria, suggesting a permeability barrier to Fe(3+) ions. This system was used to test the permeability of the mitochondrial membrane to various iron complexes of biological importance. Of the compounds tested only ferrioxamine G appeared to penetrate readily and the iron of this complex was reduced when intact mitochondria were supplied with succinate or NADH-linked substrates. The reduction was insensitive to rotenone or antimycin A. Both ferrioxamine G and ferrioxamine B were, however, reduced by particles. The membrane fraction of sonicated mitochondria was necessary for the reduction. The rate of ferrioxamine B reduction by sonicated mitochondria was measured by a dual-wavelength spectrophotometric assay and was found to be stimulated in conditions where the Fe(2+) produced was utilized for haem synthesis. The addition of FeCl(3) to anaerobic particles caused an oxidation of cytochrome b when this region of the respiratory chain was isolated by treatment with rotenone and antimycin A. These results suggest that the reduction of ferric iron and its complexes occurs inside the inner mitochondrial membrane in proximity to ferrochelatase. Possible sites for this reduction are the flavoproteins, succinate and NADH dehydrogenase.
Ultrasonic B-node scanning for study of extracranial vascular disease.
Explore the source record for details and available documents.
The use of pulmonary tests in the assessment of disability in occupational dust diseases.
Explore the source record for details and available documents.
The level and sub-cellular distribution of -aminolaevulinate synthase activity in semi-anaerobic and aerobic yeast.
Explore the source record for details and available documents.
An unusual "epidemic" in a clothing factory.
Explore the source record for details and available documents.
Giant-cell tumor of bone.
Explore the source record for details and available documents.
An unusual occupational hazard.
Explore the source record for details and available documents.
An experimental laminar-flow operating-room.
Explore the source record for details and available documents.
Ureteroureterostomy and cutaneous ureterostomy.
Explore the source record for details and available documents.
Ferrochelatase and -aminolaevulate synthetase in brain, heart, kidney and liver of normal and porphyric rats. The induction of -aminolaevulate synthetase in kidney cytosol and mitochondria by allylisopropylacetamide.
1. delta-Aminolaevulate synthetase was detected in liver and kidney mitochondria prepared from normal rats. 2. The administration of allylisopropylacetamide induced an increase in delta-aminolaevulate synthetase in both liver and kidney mitochondria and the enzyme also appeared in the cytosol fraction of both tissues. Comparison with the distribution of glutamate dehydrogenase indicated that this soluble kidney delta-aminolaevulate synthetase was truly of cytosol origin and did not arise from disrupted mitochondria. The kidney cytosol enzyme was inhibited by 50% by 50mum-protohaem. 3. delta-Aminolaevulate synthetase could not be detected in mitochondria or cytosol from heart or brain from normal or porphyric rats. 4. The administration of allylisopropylacetamide caused little or no increase in ferrochelatase or cytochrome content of liver, kidney, heart or brain mitochondria.
Factors influencing the microbiological degradation of choline and tryptophan in man.
Explore the source record for details and available documents.
An unusual hazard in forgery detection.
Explore the source record for details and available documents.
Problems in the treatment of femoral neck fractures.
Explore the source record for details and available documents.
Obstetrics in New Guinea.
Explore the source record for details and available documents.